R Margoczy

Middle Slovak Institute of Cardiovascular Diseases, Banska Bystrica, Slovakia


Articles by R Margoczy

Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study

V Blaha, R Margoczy, I Petrov, et al


Citation: European Cardiology Review 2023;18:e36.